ArticleXanthogranulomatous Reaction to Trametinib for Metastatic Malignant MelanomaAuthor:Nicole CheePublish date: October 2, 2018Trametinib, a mitogen-activated extracellular signal-regulated kinase (MEK) inhibitor, has demonstrated great promise in treating ...Read More